search
Back to results

Clinical Effectiveness of the MultiCentre Pain Monitor to Guide and Personalize Psychological Treatments: A Single Case Design

Primary Purpose

Emotional Disorder

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Multicentre Pain Monitor + Unified Protocol
Sponsored by
Universitat Jaume I
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Emotional Disorder focused on measuring Multicentre Pain Monitor, Transdiagnostic approach, Emotional Disorder, Unified Protocol, Clinical effectiveness

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Anxiety or depression problems are the main problematic symptoms
  • The patient is over 18 years of age
  • The patient is fluent in the language in which the therapy is performed (Spanish in the present study)
  • The patient is able to attend to the evaluation and treatment sessions
  • The patient signs the informed consent form

Exclusion Criteria:

  • The patient presents a severe mental disorder (bipolar disorder, schizophrenia, or an organic mental disorder) or there is suicide risk at the time of assessment
  • The patient has used substances in the last three months (excluding cannabis, coffee, and / or nicotine)
  • The patient has previously received 8 or more sessions of psychological treatment with clear and identifiable CBT principles in the past 12 months or is currently receiving psychological treatment

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    App + Unified Protocol Arm

    Arm Description

    Participants at this condition will be daily monitored by the app (Multicentre Pain Monitor) while they are administered a self-applied online transdiagnostic intervention (Unified protocol) for their emotional disorders. Alarms will be generated in the face of certain pre-set undesired events. Therapists will receive pre-set clinical alarms in real time in the presence of relevant clinical events previously determined by the clinical staff (e.g., clinical worsening or no improvement of functionality, mood or psychological mechanisms worked in therapy). This information will be used to make clinical decisions in a short period of time (e.g., call the patient, or send additional therapeutic material by mail or through the app (momentary ecological intervention), or for its implementation during the course of psychological therapy in order to make the therapy more efficient, safe, personalized and adapted to the needs of the patient

    Outcomes

    Primary Outcome Measures

    Change in Anxiety
    In a scale from 0 (not at all) to 3 (completely), "how was your level of anxiety today?"
    Change in Depression
    In a scale from 0 (not at all) to 3 (completely), "how was your level of depression today?"

    Secondary Outcome Measures

    Change in Activity level
    In a scale from 0 (minimum) to 100 (maximum), "what was your activity level today?"
    Change in Emotion Conceptualization
    In a scale from 1 (not at all) to 5 (completely), "I see difficult emotions as something bad"
    Change in Emotional Avoidance
    In a scale from 1 (not at all) to 5 (completely), "Today, I tried to get rid of my unpleasant emotions at all costs"
    Change in present-focused emotional awareness (Mindfulness)
    In a scale from 1 (not at all) to 5 (completely), "Today, it was easy for me to pay attention to the present moment non-judgmentally"
    Change in Cognitive Flexibility
    In a scale from 1 (not at all) to 5 (completely), "Today, I was able to consider different interpretations for the bad things that happened to me"
    Change in Exposure to situations
    In a scale from 1 (not at all) to 5 (completely), "Today, I tried to avoid potentially uncomfortable situations"
    Change in Exposure to physical sensations
    In a scale from 1 (not at all) to 5 (completely), "Today, I tried to get rid of my unpleasant physical sensations at all costs"

    Full Information

    First Posted
    October 18, 2021
    Last Updated
    November 4, 2021
    Sponsor
    Universitat Jaume I
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05098288
    Brief Title
    Clinical Effectiveness of the MultiCentre Pain Monitor to Guide and Personalize Psychological Treatments: A Single Case Design
    Official Title
    Clinical Effectiveness of the MultiCentre Pain Monitor to Guide and Personalize Psychological Treatments: A Single Case Design
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2021
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    December 1, 2021 (Anticipated)
    Primary Completion Date
    December 1, 2022 (Anticipated)
    Study Completion Date
    December 1, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Universitat Jaume I

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The present project aims at testing the clinical effectiveness of an app-based system called Multicentre Pain Monitor for routine outcome monitoring of adult patients with emotional disorders while they are administered a self-applied transdiagnostic psychological intervention (Unified Protocol).
    Detailed Description
    Anxiety and depressive disorders, commonly known as emotional disorders (EDs), are the most frequent mental health problems why patients seek for medical care globally. According to recent epidemiologic studies, lifetime prevalence rates reveal that anxiety and depression disorders affect approximately an estimated 31.9% and 33.7% of people worldwide, respectively. In Spain, a nationwide study showed a prevalence of anxiety and depression disorders of 5.2% and 4.1%, approximately. Consequently, EDs lead to considerable direct and indirect economic losses for countries, as well as a great negative impact on the quality of life and overall functioning of individuals. Adding up to the previous, the current covid-19 pandemic not only has boosted the incidence of mental disorders in healthy people, but also has exacerbated emotional problems in vulnerable populations. Encouragingly, the effectiveness of psychotherapy for the treatment of EDs, especially cognitive behavioural therapy (CBT), has been supported by a vast amount of scientific evidence. In particular, Internet-delivered CBT (iCBT), where patients sign in to a safe website to access online psychotherapeutic materials within several modules, has emerged in recent years as an effective alternative to face-to-face psychotherapy in an attempt to reduce costs, save therapists' and clients' time, bring psychological treatments closer to the population, and disseminate interventions easily. The growth of digital care has become even more obvious during the covid-19 pandemic and the associated quarantine, where great efforts have been made to adapt evidence-based treatments to a new digital format. Therefore, the current situation has become an opportunity to develop and implement promising digital interventions, which are now more sensible than ever. To make evidence-based treatments even more accessible, extensions and innovations of CBT have been developed in recent years. The latest research supports a transdiagnostic perspective for the treatment of EDs, where cognitive-behavioural techniques are included to target different EDs altogether. Indeed, the transdiagnostic approach appears to be an effective alternative to single disorder interventions in order to address the high comorbidity rates between anxiety and depressive disorders, as well as the shared mechanisms and the overlapping symptomatology across different disorders which play an essential role in the onset and maintenance of them. In particular, the Unified Protocol (UP), a transdiagnostic extension of CBT which works on regulate emotions in a more adaptive way through different core treatment modules, has been developed for the treatment of EDs. Specifically, the UP shows promising effects not only when delivered onsite, but also online, which makes it an excellent psychological approach to reach a large number of individuals with a single treatment protocol. In this line, some interesting proposals emphasize the need for a paradigm shift from randomized controlled trials that work on average towards personalized treatments that allow to focus more on the individual (to avoid what group average can mask). In particular, measurement-based care, which consists of routine patient monitoring, periodic feedback to the therapist (or both therapist and patient), and adaptation of the intervention according to such feedback appears to be a feasible option in order to adapt treatments to patients' needs. Fortunately, with the rapid growth of new technologies in our society such as mobile applications (apps), measurement-based care can be implemented more effectively as the apps can be used as support tools for the assessment of several psychological outcome variables. This procedure is commonly known as Ecological Momentary Assessment (EMA) and can help overcome some of the obstacles that traditional, retrospective face-to-face assessments hold. EMA has the potential to assess patients repeatedly and frequently over time, allows to observe fluctuations in patient outcomes, and early interventions can be administered in response to pre-set clinical alarms. To our knowledge, studies that use technology to improve the management of emotional problems have generally opted for using apps that report on the evolution of treatment to obtain more reliable measures of the evolution of patients or, more frequently, have used different technologies such as web pages or apps to facilitate self-applied treatments based on pre-established modules. The present study goes one step further and explores not only the usefulness of the EMA by means of an app for the improvement of the assessment process of patients with emotional problems/EDs, but also the feasibility of using it to make adjustments in real time or very short-term (e.g., in weekly visits) during the psychotherapeutic process, resembling an ecological momentary intervention (EMI). Several studies have supported the use of EMA to deliver the most personalized feedback or psychological support in real life for a given patient in order to enhance psychotherapy effectiveness and facilitate tailored treatments. Objectives The current study aims at testing the clinical effectiveness of an app-based system called Multicentric Pain Monitor, which has been recently validated in an empirical study, that monitors individuals with EDs daily and is used as an adjunct tool to the self-applied Internet-delivered transdiagnostic program (UP). The main goal is to explore whether the treatment with the innovative information and communication technologies (ICT) support is effective for persons with emotional disorders.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Emotional Disorder
    Keywords
    Multicentre Pain Monitor, Transdiagnostic approach, Emotional Disorder, Unified Protocol, Clinical effectiveness

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Model Description
    Single Case Design (n=1) (multiple baselines)
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    30 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    App + Unified Protocol Arm
    Arm Type
    Experimental
    Arm Description
    Participants at this condition will be daily monitored by the app (Multicentre Pain Monitor) while they are administered a self-applied online transdiagnostic intervention (Unified protocol) for their emotional disorders. Alarms will be generated in the face of certain pre-set undesired events. Therapists will receive pre-set clinical alarms in real time in the presence of relevant clinical events previously determined by the clinical staff (e.g., clinical worsening or no improvement of functionality, mood or psychological mechanisms worked in therapy). This information will be used to make clinical decisions in a short period of time (e.g., call the patient, or send additional therapeutic material by mail or through the app (momentary ecological intervention), or for its implementation during the course of psychological therapy in order to make the therapy more efficient, safe, personalized and adapted to the needs of the patient
    Intervention Type
    Behavioral
    Intervention Name(s)
    Multicentre Pain Monitor + Unified Protocol
    Other Intervention Name(s)
    Multicentre Pain Monitor
    Intervention Description
    The intervention will consist in a self-applied online transdiagnostic intervention for emotional problems together with an app-based EMA. In terms of monitoring, the Multicentre Pain Monitor is a mobile app whose contents have been adapted to conduct ecological momentary assessments in different health conditions. The app assesses important psychological variables, namely anxiety, depressive symptoms,etc. Participants respond daily to the questions in the app. In terms of the online self-applied intervention, the Unified Protocol is a transdiagnostic extension of CBT which works on regulate emotions in a more adaptive way through 5 core treatment modules: present-focused emotional awareness, cognitive flexibility, identification and prevention of emotional avoidance patterns, increasing awareness and tolerance to emotion-elicited physical sensations, and graded (interoceptive and situational) exposure procedures.
    Primary Outcome Measure Information:
    Title
    Change in Anxiety
    Description
    In a scale from 0 (not at all) to 3 (completely), "how was your level of anxiety today?"
    Time Frame
    Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
    Title
    Change in Depression
    Description
    In a scale from 0 (not at all) to 3 (completely), "how was your level of depression today?"
    Time Frame
    Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
    Secondary Outcome Measure Information:
    Title
    Change in Activity level
    Description
    In a scale from 0 (minimum) to 100 (maximum), "what was your activity level today?"
    Time Frame
    Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
    Title
    Change in Emotion Conceptualization
    Description
    In a scale from 1 (not at all) to 5 (completely), "I see difficult emotions as something bad"
    Time Frame
    Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
    Title
    Change in Emotional Avoidance
    Description
    In a scale from 1 (not at all) to 5 (completely), "Today, I tried to get rid of my unpleasant emotions at all costs"
    Time Frame
    Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
    Title
    Change in present-focused emotional awareness (Mindfulness)
    Description
    In a scale from 1 (not at all) to 5 (completely), "Today, it was easy for me to pay attention to the present moment non-judgmentally"
    Time Frame
    Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
    Title
    Change in Cognitive Flexibility
    Description
    In a scale from 1 (not at all) to 5 (completely), "Today, I was able to consider different interpretations for the bad things that happened to me"
    Time Frame
    Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
    Title
    Change in Exposure to situations
    Description
    In a scale from 1 (not at all) to 5 (completely), "Today, I tried to avoid potentially uncomfortable situations"
    Time Frame
    Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)
    Title
    Change in Exposure to physical sensations
    Description
    In a scale from 1 (not at all) to 5 (completely), "Today, I tried to get rid of my unpleasant physical sensations at all costs"
    Time Frame
    Change from baseline to posttreatment. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Anxiety or depression problems are the main problematic symptoms The patient is over 18 years of age The patient is fluent in the language in which the therapy is performed (Spanish in the present study) The patient is able to attend to the evaluation and treatment sessions The patient signs the informed consent form Exclusion Criteria: The patient presents a severe mental disorder (bipolar disorder, schizophrenia, or an organic mental disorder) or there is suicide risk at the time of assessment The patient has used substances in the last three months (excluding cannabis, coffee, and / or nicotine) The patient has previously received 8 or more sessions of psychological treatment with clear and identifiable CBT principles in the past 12 months or is currently receiving psychological treatment
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Carlos Suso-Ribera, Ph.D.
    Phone
    964 387643
    Email
    susor@uji.es
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Patricia Gual- Montolio
    Organizational Affiliation
    Universitat Jaume I
    Official's Role
    Study Chair
    First Name & Middle Initial & Last Name & Degree
    Juana Maria Bretón-López, Ph.D.
    Organizational Affiliation
    Universitat Jaume I
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    Individual Participant Data (IPD) will not be shared with other researchers.

    Learn more about this trial

    Clinical Effectiveness of the MultiCentre Pain Monitor to Guide and Personalize Psychological Treatments: A Single Case Design

    We'll reach out to this number within 24 hrs